# Ipamorelin and bone dimensions

> Bone dimensions | Oklahoma Functional Medicine — Oklahoma Functional Medicine examines ipamorelin's rat bone studies: mineral content, unchanged cortical volumetric density and longitudinal growth.

**The skeleton**

Amount, concentration, length. Growth becomes an absorbing subject when those measurements part company.

## Content, dimensions, density

The [bone mineral experiment](https://pubmed.ncbi.nlm.nih.gov/10828840/) studied 13-week-old female Sprague-Dawley rats over 12 weeks. Ipamorelin was delivered continuously beneath the skin by an osmotic minipump. Total tibial and vertebral bone mineral content increased, as did body weight, while cortical volumetric bone mineral density remained unchanged.

Mineral content concerns the amount present; volumetric density concerns the amount within a volume. A larger container can hold more material at the same concentration. The account describes just such a dimensional explanation for the rats' mineral gain: larger bones.

I initially wanted to compress this into a verdict about better bone. The expansion makes that adjective feel premature. The physical change impresses me; the load the resulting structure could bear remains the question. Those are compatible reactions. Even the density statement has a boundary worth preserving: it concerns cortical volumetric density, the measurement reported here.

![An educator holds a large cutaway bone model beside another showing its hollow interior](images/bone-sections.webp)

*An imagined teaching scene with enlarged bone models, used to consider dimensions and internal structure.*

## Longitudinal growth in adult female rats

The [longitudinal growth study](https://pubmed.ncbi.nlm.nih.gov/10373343/) used adult female Sprague-Dawley rats and ran for 15 days. Growth rates rose from 42 micrometres/day in the vehicle group to 44, 50 and 52 micrometres/day at increasing study doses. Total IGF-1, IGF-binding proteins and bone turnover markers did not change.

The comparison below preserves the study's daily amounts and measured growth rates. All are rat findings. I appreciate the graded response: the growth rate changed alongside unchanged blood measurements; none of these amounts supplies a human regimen.

![Four bars compare rat bone growth rates of 42, 44, 50 and 52 micrometres per day](images/rat-bone-growth.svg)

*Adult female Sprague-Dawley rats in a 15-day study. The study amounts were given beneath the skin, divided three times daily; vehicle is the comparison without ipamorelin. Source: the linked longitudinal growth study.*

## Circulating IGF-1

The authors' interpretation of the [growth result](https://pubmed.ncbi.nlm.nih.gov/10373343/) allows a partly local or growth-hormone-pulse-driven skeletal effect. That is an explanation offered for the pattern, with the absence of a measurable systemic IGF-1 change still in view.

I distrust the urge to make a blood value the master key to a tissue. This experiment makes the objection concrete: the reported bone growth and the reported circulating measurements diverged. The [hormone essay](/hormone-pulse) returns to the pulse itself and to the volunteers in whom its timing was measured.

## A direct strength measurement

For a future experiment, I favour mechanical performance alongside dimensions and mineral measurements. How much force could the bone withstand? Would a change in size come with a useful change under load?

Those questions express the benefit I would hope to see tested. The [mineral-content finding](https://pubmed.ncbi.nlm.nih.gov/10828840/) and the [longitudinal-growth finding](https://pubmed.ncbi.nlm.nih.gov/10373343/) give a starting point for asking them. I leave the imagined strength result unwritten.

---

At Oklahoma Functional Medicine, published research about bodily function satisfies my curiosity; this editorial site runs no business and supplies no medical advice.